Atopic eczema

have progressively lowered our threshold for seeking consent. We don't yet insist on written consent from patients for all case reports, but we may eventually do so. This week's case before the General Medical Council also shows that doctors must be very clear about what the patient has consented to: vague statements about the information being used in teaching and research will not be enough. Patients must be told that the material will be published, and ideally they should see a final draft of the paper to be published. Indeed, one of the expert witnesses in the case argued that doctors and patients might negotiate over what appears in the final version. Editors, who often want substantial changes in papers, must also be part ofthat process. Those who dread (as I do) the arrival of more process and bureaucracy may think that we are going too far. Surely, the argument goes, publication of reports on patients is essential for medical education and the development of medical knowledge, and the small risk that patients may be identified is outweighed by the overall benefit. But some patients are very distressed by discovering that material has been published about them without their consent; medical journals and textbooks are read by non-doctors; and most patients will give consent, which means that the advance of medical knowledge will not be impeded. We have to do better.

[1]  R. Hay,et al.  London-born black Caribbean children are at increased risk of atopic dermatitis. , 1995, Journal of the American Academy of Dermatology.

[2]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation , 1994, The British journal of dermatology.

[3]  K. Godfrey,et al.  Disproportionate fetal growth and raised IgE concentration in adult life , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  S. H. Arshad,et al.  Effect of allergen avoidance in infancy on allergic manifestations at age two years. , 1994, The Journal of allergy and clinical immunology.

[5]  J. Warner,et al.  Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  D. Strachan,et al.  Childhood eczema: disease of the advantaged? , 1994, BMJ.

[7]  S. Weiland,et al.  Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. , 1992, BMJ.

[8]  D. M. Kemény,et al.  Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  S. Tonkin,et al.  Asthma prevalence in Tokelauan children in two environments , 1980, Clinical allergy.

[10]  C Schmied,et al.  [Epidemiology of atopic dermatitis]. , 1989, Annales de dermatologie et de venereologie.

[11]  H. Beck,et al.  Atopic dermatitis, house dust mite allergy and month of birth. , 1987, Acta dermato-venereologica.